MDPI and ACS Style
Spehner, L.; Kim, S.; Vienot, A.; François, E.; Buecher, B.; Adotevi, O.; Vernerey, D.; Abdeljaoued, S.; Meurisse, A.; Borg, C.
Anti-Telomerase CD4+ Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials. Int. J. Mol. Sci. 2020, 21, 6838.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21186838
AMA Style
Spehner L, Kim S, Vienot A, François E, Buecher B, Adotevi O, Vernerey D, Abdeljaoued S, Meurisse A, Borg C.
Anti-Telomerase CD4+ Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials. International Journal of Molecular Sciences. 2020; 21(18):6838.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21186838
Chicago/Turabian Style
Spehner, Laurie, Stefano Kim, Angélique Vienot, Eric François, Bruno Buecher, Olivier Adotevi, Dewi Vernerey, Syrine Abdeljaoued, Aurélia Meurisse, and Christophe Borg.
2020. "Anti-Telomerase CD4+ Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials" International Journal of Molecular Sciences 21, no. 18: 6838.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21186838